Characterization and statistical modeling of glycosylation changes in sickle cell disease

Heather E. Ashwood, Christopher Ashwood, Anna P. Schmidt, Rebekah L. Gundry, Karin M. Hoffmeister, Waseem Q. Anani

Research output: Contribution to journalArticlepeer-review

Abstract

Sickle cell disease is an inherited genetic disorder that causes anemia, pain crises, organ infarction, and infections in 13 million people worldwide. Previous studies have revealed changes in sialic acid levels associated with red blood cell sickling and showed that stressed red blood cells bare surface-exposed clustered terminal mannose structures mediating hemolysis, but detailed glycan structures and anti-glycan antibodies in sickle cell disease remain understudied. Here, we compiled results obtained through lectin arrays, glycan arrays, and mass spectrometry to interrogate red blood cell glycoproteins and glycanbinding proteins found in the plasma of healthy individuals and patients with sickle cell disease and sickle cell trait. Lectin arrays and mass spectrometry revealed an increase in a2,6 sialylation and a decrease in a2,3 sialylation and blood group antigens displayed on red blood cells. Increased binding of proteins to immunogenic asialo and sialyl core 1, Lewis A, and Lewis Y structures was observed in plasma from patients with sickle cell disease, suggesting a heightened anti-glycan immune response. Data modeling affirmed glycan expression and plasma protein binding changes in sickle cell disease but additionally revealed further changes in ABO blood group expression. Our data provide detailed insights into glycan changes associated with sickle cell disease and refer glycans as potential therapeutic targets.

Original languageEnglish (US)
Pages (from-to)1463-1473
Number of pages11
JournalBlood Advances
Volume5
Issue number5
DOIs
StatePublished - Mar 9 2021
Externally publishedYes

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'Characterization and statistical modeling of glycosylation changes in sickle cell disease'. Together they form a unique fingerprint.

Cite this